Results 181 to 190 of about 28,832 (208)

Effect of A118G (rs1799971) single-nucleotide polymorphism of the μ-opioid receptor OPRM1 gene on intraoperative remifentanil requirements in Japanese women undergoing laparoscopic gynecological surgery. [PDF]

Neuropsychopharmacol Rep
Zou R, Nishizawa D, Inoue R, Hasegawa J, Ebata Y, Nakayama K, Hara A, Sumikura H, Kitade M, Hayashida M, Ikeda K, Kawagoe I.   +11 more
europepmc   +1 more source

In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling. [PDF]

ACS Chem Neurosci
Tsai MM, Chen L, Baumann MH, Canals M, Javitch JA, Lane JR, Shi L.   +6 more
europepmc   +1 more source

Potency, dissociation kinetics and reversibility of fentanyls and nitazenes by naloxone at the μ opioid receptor

Alhosan N, Cavallo D, Santiago M, Kelly E, Henderson G.   +4 more
europepmc   +1 more source

Carfentanil stabilizes µ opioid receptor conformations that are ultra-efficient in inhibiting cAMP, resistant to naloxone or nalmefene but sensitive to naltrexone. [PDF]

Arch Toxicol
Endt F, Guo T, Steinritz D, Amend N, Gudermann T, Breit A.   +5 more
europepmc   +1 more source

Profiling the proximal proteome of the activated μ-opioid receptor. [PDF]

Nat Chem Biol
Polacco BJ, Lobingier BT, Blythe EE, Abreu N, Khare P, Howard MK, Gonzalez-Hernandez AJ, Xu J, Li Q, Novy B, Naing ZZC, Shoichet BK, Coyote-Maestas W, Levitz J, Krogan NJ, Von Zastrow M, Hüttenhain R.   +16 more
europepmc   +1 more source

Stereoselective recognition of morphine enantiomers by μ-opioid receptor. [PDF]

Natl Sci Rev
Wang Y, Ngo VA, Wang X.
europepmc   +1 more source

Postsynaptic dopamine D₃ receptors selectively modulate μ-opioid receptor-expressing GABAergic inputs onto CA1 pyramidal cells in the rat ventral hippocampus.

J Neurophysiol
Brown KA, Stramiello M, Clark JK, Wagner JJ.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly